# Takeda Pharmaceuticals USA – FDA Inspection, Oct 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/takeda-pharmaceuticals-usa/c970fdae-8e8f-4ce7-941e-5d21130ba3ab
Source feed: FDA_Inspections

> FDA inspection 1253398 of Takeda Pharmaceuticals USA, October 16, 2024. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253398
- Company Name: Takeda Pharmaceuticals USA
- Inspection Date: 2024-10-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1313228 - 2026-04-10
- FDA Inspection 1231407 - 2024-03-22

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.keypedia.com/companies/takeda-pharmaceuticals-usa/2cc60460-dde7-47a7-968e-c06ce6a85515

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c